Drug-resistant microbes kill about 35,000 people in the U.S. per year

Aimee Cunningham

November 14, 2019

A CDC report adds two organisms to a list of five bacteria and fungi considered urgent threats

Close to 3 million people in the United States develop difficult to treat infections caused by drug-resistant bacteria and fungi each year — and about 35,000 die, according to a new government report.

“The modern medicine available to us today may very well be gone tomorrow if we don’t slow the development of antibiotic resistance,” said Robert Redfield, director of the U.S. Centers for Disease Control and Prevention in Atlanta, during a news briefing on November 13…

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as…

Putting a face on the ‘invisible threat’ of antimicrobial resistance

Mallory Smith was a young woman who, in her own words, had "big dreams and big goals." When she was…

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Name
First Last
Email
Zipcode
Organization
Title
Comments
This field is for validation purposes and should be left unchanged.

Science News

Drug-resistant microbes kill about 35,000 people in the U.S. per year

Aimee Cunningham

November 14, 2019

A CDC report adds two organisms to a list of five bacteria and fungi considered urgent threats

More

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Sign up for the latest on fighting AMR